Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

02 Dec 2019

David Sanders joins Results and leads expansion in Care Services

We are delighted to announce that David Sanders joined Results International Group as a Managing Director in the Results Healthcare…

15 Nov 2019

Private equity appetite for the life sciences sector

Private equity firms are finding more creative ways to increase their investment in the life sciences sector.  The life sciences…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

23 Mar 2020 - 8.00am-5.00pm

DCAT Week 2020

DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It…

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office